Testing effectiveness (Phase 2)Ended earlyNCT06843187
What this trial is testing
Lemborexant for the Treatment of Residual Insomnia in Major Depressive Disorder (MDD)
Who this might be right for
Major Depressive Disorder(MDD)Insomnia Comorbid to Psychiatric Disorder
Unity Health Toronto 30